SeaStar Medical (ICU) vs SiNtx Technologies (SINT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
SeaStar Medical (ICU) has outperformed SiNtx Technologies (SINT) over the past year, losing 47.0% versus a loss of 53.3%. Over five years, ICU leads with a -99.9% price change compared with -100.0% for SINT. SeaStar Medical is the larger company by market cap ($19.0 million vs $14.1 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ICU | SINT |
|---|---|---|
| Share price | $3.61 | $2.11 |
| Market cap | $18.99M | $14.06M |
| 1-day change | +3.44% | 0.00% |
| YTD return | +45.42% | -45.34% |
| 1-year return | -47.04% | -53.32% |
| 5-year return | -99.86% | -99.99% |
| EPS (TTM) | $-2.97 | $-4.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.35 | $4.64 |
| 52-week low | $2.07 | $1.40 |
| Distance from 52-week high | -50.88% | -54.53% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +177.01% | +338.39% |
| Average volume | 99.80K | 112.93K |
| Shares outstanding | 5.26M | 6.66M |
| Employees | 18 | 32 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About SeaStar Medical
ICU stock →SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis.
Health Care · Medical/Dental Instruments · 18 employees
About SiNtx Technologies
SINT stock →Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE).
Health Care · Medical/Dental Instruments · 32 employees
ICU vs SINT FAQ
Which is bigger, SeaStar Medical or SiNtx Technologies?
SeaStar Medical (ICU) is larger, with a market capitalization of $18.99M compared with $14.06M for SiNtx Technologies (SINT).
Which stock has performed better over the past year, ICU or SINT?
ICU returned -47.04% over the past 12 months, compared with -53.32% for SINT (price return, excluding dividends). Past performance does not predict future results.
Are SeaStar Medical and SiNtx Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.